Literature DB >> 10710527

IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells.

P Cohen1, R Rajah, J Rosenbloom, D J Herrick.   

Abstract

Both insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor-beta (TGF-beta) have been separately shown to have cell-specific growth-inhibiting or growth-potentiating effects. TGF-beta stimulates IGFBP-3 mRNA and peptide expression in several cell types, and TGF-beta-induced growth inhibition and apoptosis have been shown to be mediated through the induction of IGFBP-3. However, a link between the growth stimulatory effects of TGF-beta and IGFBP-3-induction has not been shown. In this study, we investigated the role of IGFBP-3 in mediating TGF-beta1-induced cell growth using human airway smooth muscle (ASM) cells as our model. TGF-beta1 (1 ng/ml) treatment induced a 10- to 20-fold increase in the levels of expression of IGFBP-3 mRNA and protein. Addition of either IGFBP-3 or TGF-beta1 to the growth medium resulted in an approximately twofold increase in cell proliferation. Coincubation of ASM cells with IGFBP-3 antisense (but not sense) oligomers as well as with an IGFBP-3 neutralizing antibody (but not with control IgG) blocked the growth induced by TGF-beta1 (P < 0.001). Several IGFBP-3-associated proteins were observed in ASM cell lysates, which may have a role in the cellular responses to IGFBP-3. These findings demonstrate that IGFBP-3 is capable of mediating the growth stimulatory effect of TGF-beta in ASM cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710527     DOI: 10.1152/ajplung.2000.278.3.L545

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  22 in total

Review 1.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 2.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 3.  The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease.

Authors:  Kian Fan Chung
Journal:  Proc Am Thorac Soc       Date:  2005

4.  Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways.

Authors:  Min Li; Changgong Li; Yi-hsin Liu; Yiming Xing; Lingyan Hu; Zea Borok; Kenny Y-C Kwong; Parviz Minoo
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

5.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

6.  Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.

Authors:  Alicia B Moore; Linda Yu; Carol D Swartz; Xaiolin Zheng; Lu Wang; Lysandra Castro; Grace E Kissling; David K Walmer; Stanley J Robboy; Darlene Dixon
Journal:  Cell Commun Signal       Date:  2010-06-10       Impact factor: 5.712

7.  Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta.

Authors:  Shaoping Xie; Maria B Sukkar; Razao Issa; Nadia M Khorasani; Kian Fan Chung
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-04-27       Impact factor: 5.464

8.  NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3.

Authors:  Saleh Ismail; Anne Sturrock; Ping Wu; Barbara Cahill; Kimberly Norman; Thomas Huecksteadt; Karl Sanders; Thomas Kennedy; John Hoidal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-26       Impact factor: 5.464

9.  Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis.

Authors:  Lindsay R Stolzenburg; Ann Harris
Journal:  Cell Tissue Res       Date:  2017-10-11       Impact factor: 5.249

10.  Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro.

Authors:  Jheri J Dupart; Jonathan C Trent; Ho-Young Lee; Kenneth R Hess; Andrew K Godwin; Takahiro Taguchi; Wei Zhang
Journal:  Mol Cancer       Date:  2009-11-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.